ArticleBMC pregnancy and childbirth2026
Factors associated with healthcare professionals' use of stigmatizing language in individuals with diabetes in pregnancy.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClinicians’ language can influence patient perception and engagement in care. Use of stigmatizing language, including terms such as “noncompliant”, “refused”, “failed”, and “unmotivated”, has been found to contribute to distress among individuals with diabetes in pregnancy. However, it is unclear how often healthcare professionals use stigmatizing language in the electronic health record (EHR) and the clinical factors associated with its use among birthing individuals with diabetes.
methodsA retrospective cohort study was conducted from 2018 to 2019, focusing on individuals with singleton, non-anomalous pregnancies diagnosed with pre-existing or gestational diabetes. We utilized an academic-community obstetric outcomes database, employing a Natural Language Processing (NLP) algorithm to identify stigmatizing terms in electronic health records, including variations of terms such as “failed,” “refused,” “unwilling,” “unmotivated,” “noncompliant,” and “non-adherent.” We then compared the clinical characteristics, outcomes, and glycemic markers of individuals with and without documented stigmatizing language. Unadjusted and adjusted logistic regression models assessed the association of clinical factors on the utilization of stigmatizing language.
resultsOut of 1,433 birthing individuals who met criteria, 128 (8.9%) exhibited stigmatizing language in their records. The most common terms were related to “noncompliant” (47%) and “refused” (42%), primarily used by physicians and nurses. Birthing individuals of color were about four times more likely to have stigmatizing language used in their EHR compared to White individuals (aOR 3.87, 95% CI 2.55–5.99, p < 0.001). Those speaking languages other than English and Spanish were three times more likely to have stigmatizing terms documented (aOR 3.18, 95% CI 1.98–5.01, p < 0.001). Finally, individuals using public insurance were nearly five times more likely to receive stigmatizing descriptions compared to those with private insurance (aOR 4.95, 95% CI 3.26–7.73, p < 0.001). No differences were seen in NICU admission after controlling for diabetes type, and few objective markers of glycemia were identified in the EHR.
conclusionBirthing individuals of color, non-English/non-Spanish speakers, and those on public insurance diagnosed with diabetes in pregnancy were significantly more likely to have stigmatizing language documented within their medical records. Clinicians’ use of stigmatizing language appears disconnected from glycemic concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.